CacyBP/SIP was mainly expressed in α-SMA-positive PASMCs, while the levels of CacyBP/SIP were lower in the pulmonary arterioles of patients with CHD-PAH, especially in the irreversible group, than in normal controls (Fig. 1A and B). Here, CACYBP is linked to pulmonary arterial hypertension.